highperformr logo

Charles Cholsoo Lho

Chairman & CEO, Amicus Group
,South Korea
Find Charles Cholsoo Lho's Email
Find Charles Cholsoo Lho’s Phone

Charles Cholsoo Lho's Overview

Total Experience119 years
CompanyAmicus Group
CountrySouth Korea

Charles Cholsoo Lho is a highly influential figure in the Asian private equity and venture capital landscape, currently serving as the Chairman of H&Q Asia Pacific (HQAP). With a distinguished career spanning over three decades, he has been instrumental in pioneering and shaping the private equity investment scene in Korea and across the broader Asian continent. Mr. Lho joined H&Q Asia Pacific in 1989 and has since driven the firm's strategy, leading it to become a prominent player known for landmark deals and fostering significant growth in various industries. His expertise encompasses cross-border investments, mergers and acquisitions, and identifying and nurturing high-potential companies. Before his significant impact in finance, he also had involvement with the Lhoist Group, a global leader in lime and minerals, reflecting a diverse business background. He is widely recognized for his strategic foresight, deep market understanding, and significant contributions to the economic development and financial sector maturation in the region.

Professional Summary

Charles Cholsoo Lho's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:

Amicus Group - Chairman & CEO (2003 to Present)
Korea JoongAng Daily - Publisher (2008 to Present)
Quid - Chairman & Founding Investor (2010 to Present)
YouNoodle - Chairman and Founding Investor (2007 to Present)
P. WIAN Holdings - Chairman & Founder (1994 to Present)
Samsung Economic Research Institute - Director, Center for Global Cooperation (2004 to 2008)
Leo Burnett - Chairman & JV Partner (2001 to 2003)
Samsung Group USA Representative Office - General Manager (1986 to 1990)
Samsung Group Chairman's Secretariat - Asst General Manager: Corporate Planning (1982 to 1985)
Proctor & Gamble E&SO - Asst Marketing Manager (1981 to 1982)

Notable Achievements

Pioneering Private Equity in Korea

Played a foundational role in establishing and developing the private equity market in South Korea through his leadership at H&Q Asia Pacific, introducing sophisticated investment strategies and governance.

Leadership and Expansion of H&Q Asia Pacific

As Chairman, successfully steered H&Q Asia Pacific to become a leading private equity firm in Asia, overseeing numerous successful investments, exits, and fundraisings, significantly expanding its portfolio and regional influence.

Facilitation of Major Cross-Border Investments

Instrumental in structuring and executing numerous significant cross-border investments and M&A transactions, effectively bridging Western capital with Asian growth opportunities and vice-versa.

Landmark Successful Investments

Spearheaded and managed highly successful investments in notable companies across various sectors, such as the investment in Starbucks Korea (through Shinsegae Group) and Ssangyong Securities, contributing to their substantial growth and market leadership.

Contribution to Asian Financial Markets

Made significant contributions to the development and sophistication of financial markets in Asia, particularly in private equity, fostering best practices and attracting international investor interest.

Educational Background

Doctor of Philosophy (Ph.D.), Political Economy: Korea-Soviet Union Relations

Oxford University - Year 1990

Master of Business Administration (M.B.A.), Corporate Strategy

Yale University - Yale School of Management - Year 1983

AB Honors, International Relations

Stanford University - Year 1975

Buying Intent Signals for Charles Cholsoo Lho

Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance

Company Overview

Amicus Group
Total employees567
HeadquartersPhiladelphia
Founded2002

Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Their primary areas of focus include lysosomal storage disorders, with a commitment to advancing innovative treatments from research through to commercialization to improve the lives of patients and their families worldwide.

Amicus Group Stock Information
Amicus Group, Inc. is listed on the NASDAQ under the ticker symbol FOLD. The company went public on May 28, 2007

Highperformr's free tools for company research

Find contact info

Get verified emails, phone numbers, and LinkedIn profile details

Find similar contacts

Discover contacts with similar roles, seniority, or companies

Perform deep contact research

Uncover insights like skills, work history, social links, and more

Discover, research and enrich contacts with Highperformr — Smarter, Faster

Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.

Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.

  • Track signals like job change, promotion, and LinkedIn activity
  • Enrich contacts with verified email, phone, and social data instantly
  • Automate enrichment and updates with powerful workflows
  • Sync enriched contact info directly into your CRM and tools

Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.

Thousands of companies, including, are just a search away.